FOLH1 and prostate carcinoma: Future studies should aim to elucidate the radiobiological mechanisms underlying the enhance in vitro cytotoxicity of [64Cu]Cu-NOTA-TP-PSMA and to assess its potential as a targeted radioligand for prostate cancer imaging and therapy.